within Pharmacolibrary.Drugs.ATC.J;

model J01DC10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 5.6666666666666664e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00023,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.019166666666666665,
    Tlag           = 15.0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DC10</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cefprozil is a second-generation cephalosporin antibiotic, used to treat a variety of bacterial infections such as pharyngitis, tonsillitis, otitis media, skin and soft tissue infections, and respiratory tract infections. It is currently an approved antibiotic in various countries and is administered primarily via the oral route.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both genders, after a single oral dose under fasting conditions.</p><h4>References</h4><ol><li><p>Barriere, SL (1992). Pharmacology and pharmacokinetics of cefprozil. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 14 Suppl 2 S184–S196. DOI:<a href=\"https://doi.org/10.1093/clinids/14.supplement_2.s184\">10.1093/clinids/14.supplement_2.s184</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1617036/\">https://pubmed.ncbi.nlm.nih.gov/1617036</a></p></li><li><p>Lin, PP, et al., &amp; Cao, Y (2021). Pharmacokinetics and Bioequivalence of Cefprozil for Suspension and Granule Formulation in Healthy Chinese Volunteers: Two Single-Dose Crossover Studies. <i>Advances in therapy</i> 38(2) 1130–1142. DOI:<a href=\"https://doi.org/10.1007/s12325-020-01593-7\">10.1007/s12325-020-01593-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33340343/\">https://pubmed.ncbi.nlm.nih.gov/33340343</a></p></li><li><p>Wise, R (1990). The pharmacokinetics of the oral cephalosporins--a review. <i>The Journal of antimicrobial chemotherapy</i> 26 Suppl E 13–20. DOI:<a href=\"https://doi.org/10.1093/jac/26.suppl_e.13\">10.1093/jac/26.suppl_e.13</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2292525/\">https://pubmed.ncbi.nlm.nih.gov/2292525</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DC10;
